ABT
ABT
US0028241000
Abbott Laboratories
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 75/100, minimal insolvency risk). The high overall score (6/7) is driven primarily by extreme stock price swings (±23.1% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.6x).

Beta (Market Relation)
0.58x
Defensive
Volatility (5Y p.a.)
23.1% p.a.
5-Year Horizon
Max Drawdown (5Y)
-41.6%
5-Year Horizon
Sharpe Ratio
-0.26
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -26.6%
3 Years 22.9% -41.1% -0.08 +0.6%
5 Years 23.1% -41.6% -0.26 -3.6%
10 Years 24.1% -41.6% 0.25 +8.5%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Historical Stress Test: Maximum peak-to-trough drawdown of -41.6% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
5 ISS Score: 5 / 10
Audit Risk
9 ISS Score: 9 / 10
Board Risk
6 ISS Score: 6 / 10
Short Ratio
2.48
ende